Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting

Abstract

This is a report from the European Society of Gynaecological Oncology State-of-the-Art Virtual Meeting held December 14–16, 2020. The unique 3-day conference offered comprehensive state-of-the-art summaries on the major advances in the treatment of different types of gynecological cancers. Sessions opened with a case presentation followed by a keynote lecture and interactive debates with opinion leaders in the field. The speakers also presented scientific reviews on the clinical trial landscape in collaboration with the European Network of Gynecological Oncological Trial (ENGOT) groups. In addition, the new ESGO-ESRTO-ESP endometrial cancer guidelines were officially presented in public. This paper describes the key information and latest studies that were presented for the first time at the conference.

Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability

“…2,[10][11][12] In patients with poor performance status, with suspicion of recurrent disease, when surgery is not the first option of treatment, or when general anesthesia has to be avoided, the tru-cut biopsy is a less invasive option than laparoscopy. [13][14][15][16][17] This review aims to look at the adequacy, accuracy and safety of the tru-cut biopsy in a large group of patients with gynecological malignancy, in relation to clinical specialty of visualization method, and to identify factors that might affect the performance, with a focus on ultrasound guidance. In daily practice, an ultrasound-guided tru-cut-biopsy is performed by different health-care providers such as gynecological oncologists, gynecologists or radiologists with ultrasound competence and Computed Tomography-guidance (CT-guided), depending on the local or regional resources.…”

22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report

“…The European Society of Gynaecological Oncology (ESGO) was founded in 1983 and became one of the largest organizations in the field. The events organized by the society attract participants and key opinion leaders from around the world 1–3. In 2021, the 22nd ESGO meeting was held in a hybrid format for the first time.…”

Best original research presented at the 23rd European Congress on Gynaecological Oncology—Best of ESGO 2022

“…The aim of this article is to provide the readers with a collection of short descriptions covering the best original studies presented during the 23rd ESGO Congress. Similar articles prepared by ENYGO authors under the supervision of ESGO experts are available from the previous editions 2–5. All accepted abstracts are published in the supplement to the International Journal of Gynecological Cancer 6…”